Palliation of Dyspnea With Mouth Piece Ventilation

Tampere University Hospital

Status: Terminated

Conditions: Dyspnea

Treatments: Device: Trilogy 100 ® (Philips Respironics)

Study type: Interventional

Funder types: Other

Identifiers

NCT03012737

R16111

Details and patient eligibility

About

An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with incurable advanced disease. Subjects are recruited from a local Hospice and from oncology ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.

Enrollment: 22 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)
• incurable advanced disease
• able to understand the study and to give informed consent
• would not gain from intensive care or resuscitation according to the treating physician

Exclusion criteria

• unable to participate and use MPV due to e.g. delirium or lack of co-operation
• the cause of the dyspnea can be succesfully treated
• unable to give informed consent

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

MPV arm

Other group

Description:

Subjects use mouth piece ventilation (MPV) accoring to their will to alleviate dyspnea for 24 hours.

Treatment:

Device: Trilogy 100 ® (Philips Respironics)